I believe I can provide some insight into that one.
There are investors who are of the opinion GLP1's are the death of CPAP, but I don't believe they are in the majority.
We have also witnessed an extraordinary amount of shorting. I can only speculate if they are current holders covering these positions until the next quarterly, Hedge funds, or Long/Short managers. You don't necessarily need a lot of sticky hands selling to get the share price move we have seen.
Take a look at Facebook and Netflix over the last 12 months for example.
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-281
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$31.27 |
Change
-0.050(0.16%) |
Mkt cap ! $19.81B | |||
| Open | High | Low | Value | Volume |
| $31.70 | $31.84 | $31.09 | $82.98M | 2.646M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22500 | $31.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.31 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |